Effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: A review of randomized controlled trials

Psychosomatic Medicine

Volumn 70, Issue 5, 2008, Pages 575-584

  Carrico, Adam W ^a   Antoni, Michael H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

AIDS; HIV; Interventions; Psychological; Psychoneuroimmunology; Randomized controlled trials

Indexed keywords

ADJUSTMENT; CLINICAL TRIAL; GROUP THERAPY; HORMONAL REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INTERVENTION STUDY; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; PSYCHOTHERAPY; REVIEW; SOCIAL SUPPORT; ADAPTIVE BEHAVIOR; BLOOD; CD4 LYMPHOCYTE COUNT; COGNITIVE THERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IMMUNOLOGY; MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; VIROLOGY; VIRUS LOAD;

HYDROCORTISONE; NORADRENALIN; PRASTERONE SULFATE; TESTOSTERONE;

ADAPTATION, PSYCHOLOGICAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEHYDROEPIANDROSTERONE SULFATE; HIV INFECTIONS; HUMANS; HYDROCORTISONE; KILLER CELLS, NATURAL; NOREPINEPHRINE; PATIENT CARE TEAM; PATIENT COMPLIANCE; PSYCHONEUROIMMUNOLOGY; PSYCHOTHERAPY, GROUP; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TESTOSTERONE; VIRAL LOAD;

EID: 50949107044     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31817a5d30     Document Type: Review

References (93)

1. Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med 2008;70:531-538
2. Heckman TG, Anderson ES, Sikkema KJ, Kochman A, Kalichman SC, Anderson T. Emotional distress in nonmetropolitan persons living with HIV disease enrolled in a telephone-delivered, coping improvement group intervention. Health Psychol 2004;23:94-100.
3. Weaver KE, Llabre MM, Duran RE, Antoni MH, Ironson G, Penedo FJ, Schneiderman N. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol 2005;24:385-392
4. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008;70:539-545
5. Moskowitz JT. Positive affect predicts lower risk of AIDS mortality. Psychosom Med 2003;65:620-626
6. Carrico AW, Ironson G, Antoni MH, Lechner SC, Duran RE, Kumar M, Schneiderman N. A path model of the effects of spirituality on depressive symptoms and 24-h urinary-free cortisol in HIV-positive persons. J Psy-chosom Res 2006;61:51-58
7. Ickovics JR, Milan S, Boland R, Schoenbaum E, Schuman P, Vlahov D. Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities. AIDS 2006;20: 1851-1860
8. Gonzalez JS, Penedo FJ, Antoni MH, Duran RE, McPherson-Baker S, Ironson G, Isabel Fernandez M, Klimas NG, Fletcher MA, Schneiderman N. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol 2004;23: 413-418
9. Moskowitz JT, Folkman S, Acree M. Do positive psychological states shed light on recovery from bereavement? Findings from a 3-year longitudinal study. Death Stud 2003;27:471-500.
10. Ironson G, Hayward H. Do positive psychosocial factors predict disease progression in HIV? A review of the evidence. Psychosom Med. 2008; 70:546-554
11. Chesney MA, Darbes LA, Hoerster K, Taylor JM, Chambers DB, Anderson DE. Positive emotions: exploring the other hemisphere in behavioral medicine. Int J Behav Med 2005;12:50-58
12. Antoni MH. Stress management and psychoneuroimmunology in HIV infection. CNS Spectr 2003;8:40-51.
13. Miller GE, Cohen S. Psychological interventions and the immune system: a meta-analytic review and critique. Health Psychol 2001;20:47-63.
14. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med 2002;137:381-433.
15. Klimas NG, Caralis P, LaPerriere A, Antoni MH, Ironson G, Simoneau J, Schneiderman N, Fletcher MA. Immunologic function in a cohort of human immunodeficiency virus type 1-seropositive and-negative healthy homosexual men. J Clin Microbiol 1991;29:1413-1421
16. Ironson G, Balbin E, Solomon G, Fahey J, Klimas N, Schneiderman N, Fletcher MA. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS 2001;15:2065-2073
17. Laurence J. Molecular interactions among herpes viruses and human immunodeficiency viruses. J Infect Dis 1990;162:338-346
18. Montagnier L, Gruest J, Chamaret S, Dauguet C, Axler C, Guétard D, Nugeyre MT, Barré-Sinoussi F, Chermann JC, Brunet JB, Klatzmann D, Gluckman JC. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science 1984;225:63-66
19. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-179
20. Cole SW. Psychosocial influences on HIV-1 disease progression: neural, endocrine and virologic mechanisms. Psychosom Med 2008;70:562-568
21. Markham PD, Salahuddin SZ, Veren K, Orndorff S, Gallo RC. Hydro-cortisone and some other hormones enhance the expression of HTLV-III. Int J Cancer 1986;37:67-72.
22. Norbiato G, Bevilacqua M, Vago T, Taddei A, Clerici. Glucocorticoids and the immune function in the human immunodeficiency virus infection: a study in hypercortisolemic and cortisol-resistant patients. J Clin Endo-crinol Metab 1997;82:3260-3263
23. Nair MPN, Mahajan S, Hou J, Sweet AM, Schwartz SA. The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells. Cell Mol Biol 2000; 46:1227-1238
24. Gougeon ML. Programmed cell death in HIV infection: dysregulation of BCL-2 and Fas pathways and contribution to AIDS pathogenesis. Psy-choneuroendocrinology 1997;22(Suppl 1):S33-S39.
25. Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, Perkins DO, Folds JD, Evans DL. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psy-chol Med 2002;32:1059-1073
26. Cole SW, Korin YD, Fahey JL, Zack JA. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 1998;161:610-616
27. Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A 2001;98: 12695-12700
28. Beck J. Cognitive Therapy: Basics and Beyond. New York: Guilford Press; 1995.
29. Antoni MH. Behavioural interventions and psychoneuroimmunology. In: Vedhara K, Irwin M, editors. Human Psychoneuroimmunology. Oxford: Oxford University Press; 2005.
30. Antoni M, Ironson G, Schneiderman N. Cognitive Behavioral Stress Management for Individuals Living with HIV: Facilitator Guide. 1st ed. Oxford: Oxford University Press; 2007.
31. Antoni M, Ironson G, Schneiderman N. Cognitive Behavioral Stress Management: Workbook. Oxford: Oxford University Press; 2007.
32. Chan I, Kong P, Leung P, Au A, Li P, Chung R, Po LM, Yu P. Cognitive-behavioral group program for Chinese heterosexual HIV-infected men in Hong Kong. Patient Educ Couns 2005;56:78-84.
33. Mulder CL, Emmelkamp PM, Antoni MH, Mulder JW, Sandfort TG, de Vries MJ. Cognitive-behavioral and experiential group psychotherapy for HIV-infected homosexual men: a comparative study. Psychosom Med 1994;56:423-431
34. Lutgendorf SK, Antoni MH, Ironson G, Starr K, Costello N, Zuckerman M, Klimas N, Fletcher MA, Schneiderman N. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men. Psychosom Med 1998;60:204-214
35. Kelly JA, Murphy DA, Bahr GR, Kalichman SC, Morgan MG, Stevenson LY, Koob JJ, Brasfield TL, Bernstein BM. Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. Am J Psychiatry 1993;150:1679-1686
36. O'Leary A, Hoff CC, Purcell DW, Gomez CA, Parsons JT, Hardnett F, Lyles CM. What happened in the SUMIT trial? Mediation and behavior change. AIDS 2005;19(Suppl 1):S111-S121.
37. Rotheram-Borus M, Murphy, DA, Wight, RG, Lee, MB, Lightfoot, M, Swendeman, D, Birnbaum, JM, Wright, W. Improving quality of life among young people living with HIV. Evaluation and Program Planning 2001;24:227-237
38. Coates TJ, McKusick L, Kuno R, Stites DP. Stress reduction training changed number of sexual partners but not immune function in men with HIV. Am J Public Health 1989;79:885-887
39. Carrico AW, Antoni MH, Weaver KE, Lechner SC, Schneiderman N. Cognitive-behavioural stress management with HIV-positive homosexual men: mechanisms of sustained reductions in depressive symptoms. Chronic Illn 2005;1:207-215
40. Antoni MH, Baggett L, Ironson G, LaPerriere A, August S, Klimas N, Schneiderman N, Fletcher MA. Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. J Consult Clin Psychol 1991;59: 906-915
41. Lutgendorf SK, Antoni MH, Ironson G, Klimas N, Kumar M, Starr K, McCabe P, Cleven K, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-type 2 antibody titers in symptomatic HIV-seropositive gay men. J Consult Clin Psychol 1997;65:31-43.
42. Carrico AW, Antoni MH, Duran RE, Ironson G, Penedo F, Fletcher MA, Klimas N, Schneiderman N. Reductions in depressed mood and denial coping during cognitive behavioral stress management with HIV-positive gay men treated with HAART. Ann Behav Med 2006;31:155-164
43. Cleary PD, Van Devanter N, Steilen M, Stuart A, Shipton-Levy R, McMullen W, Rogers TF, Singer E, Avorn J, Pindyck J. A randomized trial of an education and support program for HIV-infected individuals. AIDS 1995;9:1271-1278
44. Goodkin K, Blaney NT, Feaster DJ, Baldewicz T, Burkhalter JE, Leeds B. A randomized controlled clinical trial of a bereavement support group intervention in human immunodeficiency virus type 1-seropositive and-seronegative homosexual men. Arch Gen Psychiatry 1999;56:52-59
45. Markowitz JC, Kocsis JH, Fishman B, Spielman LA, Jacobsberg LB, Frances AJ, Klerman GL, Perry SW. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry 1998;55:452-457
46. LaPerriere AR, Antoni MH, Schneiderman N, Ironson G, Klimas N, Caralis P, Fletcher MA. Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback Self Regul 1990;15:229-242
47. Mulder CL, Antoni MH, Emmelkamp PM, Veugelers PJ, Sandfort TG, van de Vijver FA, de Vries MJ. Psychosocial group intervention and the rate of decline of immunological parameters in asymptomatic HIV-infected homosexual men. Psychother Psychosom 1995;63:185-192
48. Antoni MH, Cruess DG, Cruess S, Lutgendorf S, Kumar M, Ironson G, Klimas N, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepineph-rine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol 2000;68:31-45.
49. Antoni MH, Cruess S, Cruess DG, Kumar M, Lutgendorf S, Ironson G, Dettmer E, Williams J, Klimas N, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med 2000;22:29-37.
50. Cruess DG, Antoni MH, Schneiderman N, Ironson G, McCabe P, Fernandez JB, Cruess SE, Klimas N, Kumar M. Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men. Health Psychol 2000;19:12-20. (Pubitemid 30823637)
51. Cruess DG, Antoni MH, Kumar M, Ironson G, McCabe P, Fernandez JB, Fletcher M, Schneiderman N. Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men. Psychoneuroendocrinol-ogy 1999;24:537-549
52. Antoni MH, Cruess DG, Klimas N, Carrico AW, Maher K, Cruess S, Lechner SC, Kumar M, Lutgendorf S, Ironson G, Fletcher MA, Schnei-derman N. Increases in a marker of immune system reconstitution are predated by decreases in 24-h urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic HIV-infected men. J Psychosom Res 2005;58:3-13.
53. Cruess S, Antoni M, Cruess D, Fletcher MA, Ironson G, Kumar M, Lutgendorf S, Hayes A, Klimas N, Schneiderman N. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosom Med 2000;62:828-837
54. Carrico AW, Antoni MH, Pereira DB, Fletcher MA, Klimas N, Lechner SC, Schneiderman N. Cognitive behavioral stress management effects on mood, social support, and a marker of antiviral immunity are maintained up to 1 year in HIV-infected gay men. Int J Behav Med 2005;12:218-226
55. Antoni MH, Cruess DG, Klimas N, Maher K, Cruess S, Kumar M, Lutgendorf S, Ironson G, Schneiderman N, Fletcher MA. Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: effects on transitional naive T cells (CD4(+)CD45RA(+)CD29(+)). Am J Psychiatry 2002;159:143-145
56. Liu C, Johnson L, Ostrow D, Silvestre A, Visscher B, Jacobson LP. Predictors for lower quality of life in the HAART era among HIV-infected men. J Acquir Immune Defic Syndr 2006;42:470-477 (Pubitemid 44050896)
57. Martinez E, Milinkovic A, Buira E, de Lazzari E, Leon A, Larrousse M, Lonca M, Laguno M, Blanco J, Mallolas J, Garcia F, Miro J, Gatell J. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med 2007;8:251-258
58. Ironson G, Weiss S, Lydston D, Ishii M, Jones D, Asthana D, Tobin J, Lechner S, Laperriere A, Schneiderman N, Antoni M. The impact of improved self-efficacy on HIV viral load and distress in culturally diverse women living with AIDS: the SMART/EST Women's project. AIDS Care 2007;17:222-236
59. Goodkin K, Feaster DJ, Asthana D, Blaney NT, Kumar M, Baldewicz T, Tuttle RS, Maher KJ, Baum MK, Shapshak P, Fletcher MA. A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits. Clin Diagn Lab Immunol 1998;5:382-391
60. Goodkin K, Baldewicz TT, Asthana D, Khamis I, Blaney NT, Kumar M, Burkhalter JE, Leeds B, Shapshak P. A bereavement support group intervention affects plasma burden of human immunodeficiency virus type 1. Report of a randomized controlled trial. J Hum Virol 2001;4: 44-54.
61. Sikkema KJ, Hansen NB, Kochman A, Tate DC, Difranceisco W. Outcomes from a randomized controlled trial of a group intervention for HIV positive men and women coping with AIDS-related loss and bereavement. Death Stud 2004;28:187-209.
62. Sikkema KJ, Hansen NB, Ghebremichael M, Kochman A, Tarakeshwar N, Meade CS, Zhang H. A randomized controlled trial of a coping group intervention for adults with HIV who are AIDS bereaved: longitudinal effects on grief. Health Psychol 2006;25:563-570 (Pubitemid 44600917)
63. Bangsberg DR, Acosta EP, Gupta R, Guzman D, Riley ED, Harrigan PR, Parkin N, Deeks SG. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS 2006;20:223-231
64. Johnson MO, Catz SL, Remien RH, Rotheram-Borus MJ, Morin SF, Charlebois E, Gore-Felton C, Goldsten RB, Wolfe H, Lightfoot M, Chesney MA. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the healthy living project. AIDS Patient Care STDS 2003;17:645-656
65. Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med 2003;11:185-198
66. Antoni MH, Carrico AW, Duran RE, Spitzer S, Penedo F, Ironson G, Fletcher MA, Klimas N, Schneiderman N. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med 2006;68:143-151
67. Safren S, Knauz RO, O'Cleirigh C, Lerner J, Greer J, Harwood M, Tan J, Mayer KH. CBT for HIV medication adherence and depression: process and outcome at post-treatment and three-month cross over. Ann Behav Med 2006;31:S006.
68. Motivala SJ, Hurwitz BE, Llabre MM, Klimas NG, Fletcher MA, Antoni MH, LeBlanc WG, Schneiderman N. Psychological distress is associated with decreased memory helper T-cell and B-cell counts in pre-AIDS HIV seropositive men and women but only in those with low viral load. Psychosom Med 2003;65:627-635
69. Taylor DN. Effects of a behavioral stress-management program on anxiety, mood, self-esteem, and T-cell count in HIV positive men. Psychol Rep 1995;76:451-457
70. Auerbach J, Oleson, TD, Solomon, GF. A behavioral medicine intervention as an adjunctive treatment for HIV-related illness. Psychology and Health 1992;6:325-334
71. Eller L. Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV. Ann Behav Med 1995;17:339-348
72. Bormann JE, Gifford AL, Shively M, Smith TL, Redwine L, Kelly A, Becker S, Gershwin M, Bone P, Belding W. Effects of spiritual mantram repetition on HIV outcomes: a randomized controlled trial. J Behav Med 2006;29:359-376
73. Diego MA, Field T, Hernandez-Reif M, Shaw K, Friedman L, Ironson G HIV adolescents show improved immune function following massage therapy. Int J Neurosci 2001;106:35-45.
74. Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol 1998;66:174-184
75. Pennebaker JW, Seagal JD. Forming a story: the health benefits of narrative. J Clin Psychol 1999;55:1243-1254
76. Langens TA, Schuler J. Effects of written emotional expression: the role of positive expectancies. Health Psychol 2007;26:174-182
77. Petrie KJ, Fontanilla I, Thomas MG, Booth RJ, Pennebaker JW. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom Med 2004;66:272-275
78. Spiegel D. Mind matters-group therapy and survival in breast cancer. N Engl J Med 2001;345:1767-1768
79. Cruess DG, Antoni MH, Kumar M, Schneiderman N. Reductions in salivary cortisol are associated with mood improvement during relaxation training among HIV-seropositive men. J Behav Med 2000;23:107-122
80. Ironson G, Friedman A, Klimas N, Antoni M, Fletcher MA, Laperriere A, Simoneau J, Schneiderman N. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med 1994;1: 90-105.
81. Chesney M, Folkman S, Chambers D. Coping effectiveness training for men living with HIV: preliminary findings. Int J STD AIDS 1996; 7(Suppl 2):75-82.
82. Chesney MA, Chambers DB, Taylor JM, Johnson LM, Folkman S. Coping effectiveness training for men living with HIV: results from a randomized clinical trial testing a group-based intervention. Psychosom Med 2003;65:1038-1046
83. Heckman TG, Carlson B. A randomized clinical trial of two telephone-delivered, mental health interventions for HIV-infected persons in rural areas of the United States. AIDS Behav 2007;11:5-14.
84. Heckman TG, Barcikowski R, Ogles B, Suhr J, Carlson B, Holroyd K, Garske J. A telephone-delivered coping improvement group intervention for middle-aged and older adults living with HIV/AIDS. Ann Behav Med 2006;32:27-38.
85. Pereira DB, Antoni MH, Danielson A, Simon T, Efantis-Potter J, Carver CS, Duran RE, Ironson G, Klimas N, O'Sullivan MJ. Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med 2003;65: 427-434
86. Laperriere A, Ironson GH, Antoni MH, Pomm H, Jones D, Ishii M, Lydston D, Lawrence P, Grossman A, Brondolo E, Cassells A, Tobin JN, Schneiderman N, Weiss SM. Decreased depression up to one year following CBSM+ intervention in depressed women with AIDS: the smart/ EST women's project. J Health Psychol 2005;10:223-231
87. West-Edwards C, Pereira D, Greenwood D, Antoni MH, Ironson G, Duran R, Fletcher MA, Schneiderman N. An investigation of the psychological and immune effects of a cognitive behavioral stress management (CBSM) intervention for HIV+ African American women. Ann Behav Med 2001;23:12.
88. Rotheram-Borus MJ, Lee MB, Gwadz M, Draimin B. An intervention for parents with AIDS and their adolescent children. Am J Public Health 2001;91:1294-1302
89. Stein MD, Herman DS, Bishop D, Anderson BJ, Trisvan E, Lopez R, Flanigan T, Miller I. A telephone-based intervention for depression in HIV patients: negative results from a randomized clinical trial. AIDS Behav 2007;11:15-23.
90. Szapocznik J, Feaster DJ, Mitrani VB, Prado G, Smith L, Robinson-Batista C, Schwartz SJ, Mauer MH, Robbins MS. Structural ecosystems therapy for HIV-seropositive African American women: effects on psychological distress, family hassles, and family support. J Consult Clin Psychol 2004;72:288-303.
91. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001;58:721-728
92. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I. Increased human immunodeficiency virus loads in active methamphet-amine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 2003;188:1820-1826
93. Carrico AW, Johnson MO, Moskowitz JT, Neilands TB, Morin SF, Charlebois ED, Steward WT, Remien RH, Lightfoot MA, Rotheram-Borus MJW, FL, Chesney MA. Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy. Psychosom Med 2007;69:785-792